DK1945647T3 - Fremgangsmåder til fremstilling af maytansinol - Google Patents

Fremgangsmåder til fremstilling af maytansinol

Info

Publication number
DK1945647T3
DK1945647T3 DK06844315.9T DK06844315T DK1945647T3 DK 1945647 T3 DK1945647 T3 DK 1945647T3 DK 06844315 T DK06844315 T DK 06844315T DK 1945647 T3 DK1945647 T3 DK 1945647T3
Authority
DK
Denmark
Prior art keywords
maytansinol
methods
bridged
preparing maytansinol
preparing
Prior art date
Application number
DK06844315.9T
Other languages
English (en)
Inventor
Ravi V J Chari
Wayne C Widdison
Original Assignee
Immunogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunogen Inc filed Critical Immunogen Inc
Application granted granted Critical
Publication of DK1945647T3 publication Critical patent/DK1945647T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK06844315.9T 2005-11-08 2006-11-08 Fremgangsmåder til fremstilling af maytansinol DK1945647T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73433005P 2005-11-08 2005-11-08
PCT/US2006/043718 WO2007056550A2 (en) 2005-11-08 2006-11-08 Processes for preparation of maytansinol

Publications (1)

Publication Number Publication Date
DK1945647T3 true DK1945647T3 (da) 2012-05-07

Family

ID=38024003

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06844315.9T DK1945647T3 (da) 2005-11-08 2006-11-08 Fremgangsmåder til fremstilling af maytansinol

Country Status (10)

Country Link
US (1) US7411063B2 (da)
EP (1) EP1945647B9 (da)
JP (1) JP5117390B2 (da)
AT (1) ATE540956T1 (da)
AU (1) AU2006311485B2 (da)
CA (1) CA2625867C (da)
DK (1) DK1945647T3 (da)
ES (1) ES2380687T3 (da)
PL (1) PL1945647T3 (da)
WO (1) WO2007056550A2 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
AU2002311919B8 (en) 2001-05-11 2007-03-22 Ludwig Institute For Cancer Research Ltd Specific binding proteins and uses thereof
US9090693B2 (en) 2007-01-25 2015-07-28 Dana-Farber Cancer Institute Use of anti-EGFR antibodies in treatment of EGFR mutant mediated disease
CA2680854C (en) 2007-03-15 2017-02-14 Ludwig Institute For Cancer Research Treatment method using egfr antibodies and src inhibitors and related formulations
CN108424454B (zh) 2007-08-14 2022-05-31 路德维格癌症研究所有限公司 靶向egf受体的单克隆抗体175及其衍生物和用途
FR2949469A1 (fr) * 2009-08-25 2011-03-04 Sanofi Aventis Derives anticancereux, leur preparation et leur application en therapeutique
US20120121615A1 (en) 2010-11-17 2012-05-17 Flygare John A Alaninyl maytansinol antibody conjugates
CA2891280C (en) 2012-11-24 2018-03-20 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
US10208125B2 (en) 2013-07-15 2019-02-19 University of Pittsburgh—of the Commonwealth System of Higher Education Anti-mucin 1 binding agents and uses thereof
TWI541022B (zh) 2013-12-18 2016-07-11 應克隆公司 針對纖維母細胞生長因子受體－３（ｆｇｆｒ３）之化合物及治療方法
US10464955B2 (en) 2014-02-28 2019-11-05 Hangzhou Dac Biotech Co., Ltd. Charged linkers and their uses for conjugation
TW201711702A (zh) 2015-06-04 2017-04-01 應克隆公司 使用針對纖維母細胞生長因子受體３（ｆｇｆｒ３）之化合物的療法
NZ739830A (en) 2015-07-12 2021-12-24 Hangzhou Dac Biotech Co Ltd Bridge linkers for conjugation of cell-binding molecules
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
KR20220150408A (ko) 2016-11-14 2022-11-10 항저우 디에이씨 바이오테크 씨오, 엘티디 결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
EP3554544A4 (en) 2016-12-16 2020-07-29 Bluefin Biomedicine, Inc. ANTI-PROTEIN 1 ANTIBODY CONTAINING AN ANTI-CUB DOMAIN (CDCP1), ANTIBODY-DRUG CONJUGATES AND THEIR METHODS OF USE
KR102667230B1 (ko) * 2019-03-01 2024-05-21 셀진 코포레이션 마이탄시놀의 제조
US11420981B2 (en) 2019-04-18 2022-08-23 Indena S.P.A. Diasteroselective process for the preparation of thiol- or disulfide-containing maytansinoid esters and intermediates thereof
US11555019B2 (en) 2019-07-10 2023-01-17 Cybrexa 3, Inc. Peptide conjugates of microtubule-targeting agents as therapeutics
MX2022000449A (es) 2019-07-10 2022-04-25 Cybrexa 2 Inc Conjugados peptídicos de citotoxinas como terapéuticos.
JP7772363B2 (ja) 2019-11-29 2025-11-18 日本マイクロバイオファーマ株式会社 メイタンシノールの酵素的生産方法
EP4426727A2 (en) 2021-11-03 2024-09-11 Hangzhou Dac Biotech Co., Ltd. Specific conjugation of an antibody

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5566586A (en) * 1978-11-14 1980-05-20 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
US6333410B1 (en) 2000-08-18 2001-12-25 Immunogen, Inc. Process for the preparation and purification of thiol-containing maytansinoids
AU2003228998A1 (en) * 2002-05-13 2003-12-02 Smithkline Beecham Corporation Process for preparing maytansinol

Also Published As

Publication number Publication date
CA2625867A1 (en) 2007-05-18
CA2625867C (en) 2014-12-23
US7411063B2 (en) 2008-08-12
WO2007056550A2 (en) 2007-05-18
EP1945647B9 (en) 2012-11-14
ES2380687T3 (es) 2012-05-17
JP2009514978A (ja) 2009-04-09
EP1945647B1 (en) 2012-01-11
JP5117390B2 (ja) 2013-01-16
ATE540956T1 (de) 2012-01-15
EP1945647A4 (en) 2010-10-20
EP1945647A2 (en) 2008-07-23
WO2007056550A3 (en) 2007-12-06
PL1945647T3 (pl) 2012-04-30
AU2006311485A1 (en) 2007-05-18
AU2006311485B2 (en) 2012-09-27
US20070112188A1 (en) 2007-05-17

Similar Documents

Publication Publication Date Title
DK1945647T3 (da) Fremgangsmåder til fremstilling af maytansinol
DK1633697T3 (da) Fremgangsmåde til fremstilling af substituerede 3-aryl-butyl-aminforbindelser
ATE427965T1 (de) Antikírper gegen 25-hydroxyvitamin d
EA200702550A1 (ru) Способ получения эпоксида
ECSP056111A (es) Derivados de 2-acilamino-4-feniltiazol, su preparación y aplicación en terapeutica
SE0300924D0 (sv) A method to provide a triple well in an epitaxially based CMOS or BiCMOS process
EA200700199A1 (ru) Способ получения дигидроптеридинонов
WO2005016879A3 (en) Cyclic pyrazinoylguanidine sodium channel blockers
ATE497853T1 (de) Werkzeuganordnung
EA201100517A1 (ru) Способ получения дабигатрана и его промежуточные соединения
EA200801560A1 (ru) Бифенилкарбоксамиды
DK2089371T3 (da) Fremstillingsmåde til fremstilling af hexahydrofuro[2,3-b]furan-3-OL
FR2862644B1 (fr) Utilisation de ressources renouvelables
DE602006017172D1 (de) Prozesskonfiguration in einem netzwerk
TW200617040A (en) Functional siloxanes and silanes and their vinyl co-polymers
DK1756049T3 (da) Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater
EA200602169A1 (ru) Способ получения производных 2-оксо-1-пирролидина внутримолекулярным аллилированием
EA200501829A1 (ru) Способ получения непептидных замещённых спиробензоазепиновых производных
EA200700550A1 (ru) Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
DE602004030231D1 (de) Pyrimidinonverbindungen als calcilytica
EA200801573A1 (ru) Способ получения кристаллических форм орлистата
EA201001872A1 (ru) Новые способы получения производных циклопропиламида
SE0300765D0 (sv) Process for manufacture of an allyl ether
DK1926732T3 (da) Fremgangsmåde til fremstillingen af carbapenemforbindelser
DE602004022874D1 (de) Biotransformation von colchicinoidverbindungen